UBS Group’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-7,576
| Closed | -$12K | – | 9382 |
|
2025
Q1 | $12K | Buy |
7,576
+6,945
| +1,101% | +$11K | ﹤0.01% | 7211 |
|
2024
Q4 | $2.11K | Buy |
631
+617
| +4,407% | +$2.07K | ﹤0.01% | 7862 |
|
2024
Q3 | $26 | Sell |
14
-25,044
| -100% | -$46.5K | ﹤0.01% | 8074 |
|
2024
Q2 | $49.4K | Buy |
25,058
+25,042
| +156,513% | +$49.3K | ﹤0.01% | 5556 |
|
2024
Q1 | $49 | Sell |
16
-830
| -98% | -$2.54K | ﹤0.01% | 7757 |
|
2023
Q4 | $1.97K | Buy |
846
+662
| +360% | +$1.54K | ﹤0.01% | 6970 |
|
2023
Q3 | $744 | Sell |
184
-902
| -83% | -$3.65K | ﹤0.01% | 7156 |
|
2023
Q2 | $4.45K | Buy |
1,086
+721
| +198% | +$2.96K | ﹤0.01% | 6450 |
|
2023
Q1 | $1.12K | Sell |
365
-2,672
| -88% | -$8.23K | ﹤0.01% | 7704 |
|
2022
Q4 | $8.2K | Buy |
3,037
+2,456
| +423% | +$6.63K | ﹤0.01% | 7613 |
|
2022
Q3 | $2K | Sell |
581
-1
| -0.2% | -$3 | ﹤0.01% | 8674 |
|
2022
Q2 | $4K | Buy |
582
+568
| +4,057% | +$3.9K | ﹤0.01% | 8104 |
|
2022
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 9660 |
|
2021
Q4 | $0 | Sell |
14
-211
| -94% | – | ﹤0.01% | 9432 |
|
2021
Q3 | $6K | Sell |
225
-180
| -44% | -$4.8K | ﹤0.01% | 7304 |
|
2021
Q2 | $26K | Buy |
405
+35
| +9% | +$2.25K | ﹤0.01% | 5996 |
|
2021
Q1 | $46K | Sell |
370
-1,700
| -82% | -$211K | ﹤0.01% | 5642 |
|
2020
Q4 | $236K | Buy |
2,070
+777
| +60% | +$88.6K | ﹤0.01% | 4182 |
|
2020
Q3 | $155K | Sell |
1,293
-134
| -9% | -$16.1K | ﹤0.01% | 4124 |
|
2020
Q2 | $178K | Buy |
1,427
+861
| +152% | +$107K | ﹤0.01% | 4086 |
|
2020
Q1 | $109K | Buy |
566
+300
| +113% | +$57.8K | ﹤0.01% | 4368 |
|
2019
Q4 | $89K | Buy |
266
+83
| +45% | +$27.8K | ﹤0.01% | 5030 |
|
2019
Q3 | $59K | Buy |
183
+119
| +186% | +$38.4K | ﹤0.01% | 5170 |
|
2019
Q2 | $28K | Buy |
64
+37
| +137% | +$16.2K | ﹤0.01% | 5519 |
|
2019
Q1 | $15K | Sell |
27
-93
| -78% | -$51.7K | ﹤0.01% | 5718 |
|
2018
Q4 | $36K | Buy |
+120
| New | +$36K | ﹤0.01% | 5450 |
|
2018
Q3 | – | Sell |
-11
| Closed | -$7K | – | 7192 |
|
2018
Q2 | $7K | Buy |
11
+6
| +120% | +$3.82K | ﹤0.01% | 6425 |
|
2018
Q1 | $14K | Buy |
+5
| New | +$14K | ﹤0.01% | 5789 |
|